Methods. We present a case of native aortic valve endocarditis due to Lactococcus garvieae with severe aortic insufficiency requiring valve replacement.
Results. The patient is a sixty year old male with history of Waldenstrom's macroglobulinemia for which he had been receiving intravenous immunoglobulin infusions for the previous two years. He was admitted to the hospital with a two week history of fatigue, decreased appetite and worsening shortness of breath. Chest radiograph showed findings consistent with interstitial pulmonary edema. Blood cultures grew Lactococcus garvieae. A transesophageal echocardiogram showed a mobile echodensity on the aortic valve extending into the left ventricular outflow tract; there was associated leaflet perforation and severe aortic regurgitation. Two thirds of the aortic valve leaflets were essentially destroyed. The patient underwent aortic valve replacement with a pericardial valve. Surveillance blood cultures and cultures of the resected valve were negative. He was treated with vancomycin and gentamicin for two weeks, followed by ceftriaxone for a total of six weeks. The patient has done well since discharge from the hospital, with a follow up transthoracic echocardiogram showing a normally functioning bioprosthetic aortic valve.
Lactococcus. was placed in a separate genus from Streptococcus in 1985 based on genetic analysis. L. garvieae is a catalase-negative, facultatively anaerobic, serogroup N, gram-positive coccus. A review of the English literature revealed fifteen cases of infective endocarditis due to L. garvieae. More than half of the patients had a prosthetic or repaired valve. Most patients were treated medically with the majority receiving a six week course of β-lactams. All but one patients survived.
Conclusion. Lactococcus garvieae is an extremely uncommon cause of infective endocarditis. β-lactams appear to be the antibiotics of choice, and the prognosis is favorable. We believe our patient represents the first case in the US that required valve replacement.
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